Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Tyra Biosciences Inc (TYRA)

Tyra Biosciences Inc (TYRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
TYRA BIOSCIENCES AND BCAN ESTABLISH MAY 21 AS UPPER TRACT UROTHELIAL CANCER (UTUC) AWARENESS DAY PR Newswire - Thu May 21, 7:00AM CDT

-Collaboration aims to raise awareness of UTUC and the need for continued innovation for patients living with this rare and difficult-to-treat cancer-

TYRA : 29.42 (-7.89%)
Tyra Biosciences Earnings May Expose Whether Wall Street Confused Pipeline Activity With Progress Barchart - Wed May 13, 4:05PM CDT

Barchart Research What to Expect from TYRA Earnings TYRA Generated May 13, 2026 Current Price $36.18 EPS Estimate $$-0.60 Consensus Rating Strong Buy Average Move 3.14% Tyra Biosciences Earnings May Expose...

TYRA : 29.42 (-7.89%)
Tyra Biosciences Reports First Quarter 2026 Financial Results and Recent Highlights PR Newswire - Wed May 13, 7:00AM CDT

- Advanced " dabogratinib 3x3 "  strategy to pursue 3 late-stage clinical studies in LG-UTUC, IR NMIBC and ACH -

TYRA : 29.42 (-7.89%)
Tyra Biosciences to Participate in Upcoming Investor Conferences PR Newswire - Thu May 7, 3:05PM CDT

CARLSBAD, Calif. , May 7, 2026 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target...

TYRA : 29.42 (-7.89%)
Tyra Biosciences Announces Appointment of Habib Dable to its Board of Directors PR Newswire - Fri Apr 17, 7:00AM CDT

- Seasoned biopharmaceutical leader brings deep commercial and strategic expertise to support TYRA's next phase of growth-

TYRA : 29.42 (-7.89%)
Tyra Biosciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights PR Newswire - Mon Mar 2, 3:05PM CST

- Launched " dabogratinib 3x3 "  strategy to pursue 3 late-stage clinical studies in LG-UTUC, IR NMIBC and ACH, 3 potential blockbuster indications -

TYRA : 29.42 (-7.89%)
Tyra Biosciences Announces Poster Presentations at the 2026 ASCO® Genitourinary (GU) Cancers Symposium PR Newswire - Mon Feb 23, 4:30PM CST

CARLSBAD, Calif. , Feb. 23, 2026 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target...

TYRA : 29.42 (-7.89%)
Tyra Biosciences to Participate in Upcoming Investor Conferences PR Newswire - Thu Feb 19, 3:05PM CST

CARLSBAD, Calif. , Feb. 19, 2026 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target...

TYRA : 29.42 (-7.89%)
Tyra Biosciences Strengthens Leadership Team with Appointments of Bhavesh Ashar as Chief Operating Officer and Heather Faulds as Chief Regulatory Officer PR Newswire - Mon Dec 1, 2025

CARLSBAD, Calif. , Dec. 1, 2025 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target...

TYRA : 29.42 (-7.89%)
Medical Laboratory by Gorodenkoff via Shutterstock
3 Biotech Stocks Wall Street Analysts Predict Will More Than Double Barchart - Thu Nov 20, 2025

What makes analysts so bullish about these three names from the sector?

MEHCQ : 3.5000 (-2.78%)
GHRS : 26.33 (-2.05%)
TYRA : 29.42 (-7.89%)
DMAC : 7.38 (+4.83%)
XBI : 156.74 (-0.95%)

Barchart Exclusives

This Analyst Just Upped the Price Target on SanDisk Stock. Here's Why. Barchart - 13 minutes ago
Bank of America sees significant further upside in SanDisk stock. Analyst Wamsi Mohan explained why in his latest research note. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.